Paper40932259
Cystic fibrosis: Correction of a fatal disease.
Friedman JM. Proc Natl Acad Sci U S A, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Cystic fibrosis: Correction of a fatal disease. Papers, record 40932259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40932259
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Humans | |
| Cystic Fibrosis Transmembrane Conductance Regulator | |
| Mutation | |
| Animals |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7300874 | Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. | N Engl J Med | 1981 | https://conductscience.org/library/papers/7300874 | PubMed |
| 2 | 2475911 | Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. | Science | 1989 | https://conductscience.org/library/papers/2475911 | PubMed |
| 3 | 30334692 | VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. | N Engl J Med | 2018 | https://conductscience.org/library/papers/30334692 | PubMed |
| 4 | 10461154 | Cell-based assays and instrumentation for screening ion-channel targets. | Drug Discov Today | 1999 | https://conductscience.org/library/papers/10461154 | PubMed |
| 5 | 3862125 | Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3862125 | PubMed |
| 6 | 1699669 | Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. | Cell | 1990 | https://conductscience.org/library/papers/1699669 | PubMed |
| 7 | 36264792 | Molecular structures reveal synergistic rescue of Δ508 CFTR by Trikafta modulators. | Science | 2022 | https://conductscience.org/library/papers/36264792 | PubMed |
| 8 | 1380673 | Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. | Nature | 1992 | https://conductscience.org/library/papers/1380673 | PubMed |
| 9 | 6823316 | Chloride impermeability in cystic fibrosis. | Nature | 1983 | https://conductscience.org/library/papers/6823316 | PubMed |
| 10 | 1722350 | Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. | Science | 1991 | https://conductscience.org/library/papers/1722350 | PubMed |
| 11 | 25607428 | Origins of cystic fibrosis lung disease. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25607428 | PubMed |
| 12 | 1722027 | Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. | Nature | 1991 | https://conductscience.org/library/papers/1722027 | PubMed |
| 13 | 36849331 | Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. | J Cyst Fibros | 2023 | https://conductscience.org/library/papers/36849331 | PubMed |
| 14 | 16443646 | Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. | Am J Physiol Lung Cell Mol Physiol | 2006 | https://conductscience.org/library/papers/16443646 | PubMed |
| 15 | 7537452 | cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein. | Am J Physiol | 1995 | https://conductscience.org/library/papers/7537452 | PubMed |
| 16 | 39145455 | The forgotten pandemic: how understanding cholera illuminated mechanisms of chloride channels in multiple diseases. | J Clin Invest | 2024 | https://conductscience.org/library/papers/39145455 | PubMed |
| 17 | 6327771 | Defective beta adrenergic response of cystic fibrosis sweat glands in vivo and in vitro. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6327771 | PubMed |
| 18 | 22047557 | A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. | N Engl J Med | 2011 | https://conductscience.org/library/papers/22047557 | PubMed |
| 19 | 1712984 | Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. | Science | 1991 | https://conductscience.org/library/papers/1712984 | PubMed |
| 20 | 9195864 | Improved indicators of cell membrane potential that use fluorescence resonance energy transfer. | Chem Biol | 1997 | https://conductscience.org/library/papers/9195864 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40932259
GET https://conductscience.org/api/papers/v1/40932259/authors